APA Цитирование

Vorasettakarnkij, Y., Medina, H. M., Ahmed, W., Holmvang, G., Deeprasertkul, P., Verdini, D. J., . . . Sosnovik, D. E. (2011). The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis. BioMed Central.

Chicago-стиль цитирования

Vorasettakarnkij, Yongkasem, et al. The Utility of Delayed-enhancement and T2-weighted Cardiovascular Mri for Predicting Clinical Outcomes in Patients At High Risk for Cardiac Sarcoidosis. BioMed Central, 2011.

MLA-цитирование

Vorasettakarnkij, Yongkasem, et al. The Utility of Delayed-enhancement and T2-weighted Cardiovascular Mri for Predicting Clinical Outcomes in Patients At High Risk for Cardiac Sarcoidosis. BioMed Central, 2011.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.